Immunomodulator
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 (NCT04701502) | Catalysis SL | 2020-11-09 |
Track Immunomodulator automatically
Every clearance here is in the API, with alerts when new ones post.